Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Famon Awal Bros Sedaya Tbk. (PRAY) Price & Performance

UBC Medical Indonesia Tbk.Trade
Famon Awal Bros Sedaya Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Famon Awal Bros Sedaya Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume), while Famon Awal Bros Sedaya Tbk. trades at Rp795 (market cap 10.33T, 50.1K 24h volume). The key difference: Famon Awal Bros Sedaya Tbk. is far larger — about 16.2× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (843K versus 50.1K). Which is the better fit depends on your goals.

LABSPRAY
Market Cap
635.95B10.33T
Volume
843K50.1K
Lot
8.43K501
Turnover
137.6M38.09M
Average Price
163.22760.32
Value
137.6M38.09M
Indicative Equilibrium Price
165745
Indicative Equilibrium Volume
2461

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
PRAY
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Famon Awal Bros Sedaya Tbk.

PT Famon Awal Bros Sedaya Tbk (the Company) was originally named as PT Famon Global Rayawhich was established based on Notarial Deed No. 74 dated 2 March 1997 of Irawan Soerodjo, S.H.,Notary in Jakarta. The Company strated its commercial operations in 1998.

Read more on PRAY